At a time when financial prudence defines the margins of elite football, Arsenal are showing how clarity of planning and control can shape a compelling transfer pursuit. As reported by ...

His studies showed that a B vitamin deficiency could cause hardened arteries. It took the medical profession more than a ...

The approval of iptacopan in reducing proteinuria in adult patients with native kidney C3G was based on data from the randomized, double-blind, placebo-controlled, phase 3 APPEAR-C3G trial.

Novartis' Fabhalta has become the first treatment approved by the FDA for the ultra-rare kidney disease C3G. But analysts ...

A total of 120 clinical investigative sites across 30 countries have been chosen for clinical trial participation in the zaltenibart Phase 3 program in PNH, a good number of which have already ...

Novartis receives third FDA approval for oral Fabhalta® (iptacopan) – the first and only treatment approved in C3 glomerulopathy (C3G) Fabhalta is the only oral alternative complement pathway ...

The Rockets have their focus on the playoffs but for the next two weeks they should keep an eye on these potential ...

The Competition for Osimhen As the transfer window approaches, Arsenal and Manchester United have emerged as frontrunners in the race to acquire Osimhen. Both clubs, known for their storied histories ...

Nitro saw seven players get into the scoring column during Wednesday’s boys basketball state tournament quarterfinal against ...

The team could use help at wide receiver, and adding another running back to the mix to complement D'Andre Swift wouldn't be a bad idea. While the best course of action at running back would be to ...